Products | October 01, 2009

MammoSite ML Delivers Therapy in Five Days

Related Content

Study points to options to improve quality of life for patients whose cancer is cured with chemoradiation

Sexual Activity and Vaginal Dilation Associated with Fewer Side Effects After Cervical Cancer Treatment

October 1, 2023 — People who engage in sexual activity or vaginal dilation after chemoradiation treatment for cervical ...

October 01, 2023

Next-generation system helps improve surgical precision to enhance patient care in breast and other soft tissue cancer treatment

News | Brachytherapy Systems

Merit Medical Receives FDA Breakthrough Device Designation for the New SCOUT MD Surgical Guidance System

February 23, 2023 — Merit Medical Systems, Inc., a leading global manufacturer and marketer of healthcare technology ...

February 23, 2023

BSC coordinates QUSTom, the first project that will use supercomputing to detect tumors more effectively and safely. The new imaging modality will improve breast cancer diagnosis and potentially replace mammograms

News | Ultrasound Women's Health

New Project Coordinated by the BSC Aims to Revolutionize the Detection of Breast Cancer Using Ultrasound Imaging

May 16, 2022 — The Barcelona Supercomputing Center (BSC) coordinates QUSTom (Quantitative Ultrasound Stochastic ...

May 16, 2022

This is a 360 degree view inside one of the brachytherapy treatment rooms at the Northwestern Medicine's center center in Warrenville, Ill., in the western suburbs of Chicago. The room is equipped with a Varian VariSource brachytherapy afterloader.

360 Photos | Brachytherapy Systems

Brachytherapy Treatment Room 360 Degree View at Northwestern Medicine

This is a 360 degree view inside one of the brachytherapy treatment rooms at Northwestern Medicine's center in ...

October 28, 2021

Patients treated with Xoft Brain IORT lived for a range of 4 to 54 months after treatment without recurrence, whereas patients in the control group had a recurrence within 2 to 10 months and lived for 2 to 22.5 months after treatment

News | Brachytherapy Systems

iCAD’s Xoft Brain IORT Demonstrates Significant Improvement in Overall Survival in Recurrent Glioblastoma

August 31, 2021 — iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy ...

August 31, 2021

Prof. Jayant Vaidya, lead author of the study, University College London surgery and interventional science, performs a TARGI-IORT procedure. A small ball-shaped device placed inside the breast, directly where the cancer had been. The single-dose treatment lasts for around 20-30 minutes and replaces the need for extra hospital visits in eight out of ten cases.

News | Radiation Oncology

Pioneering Single-dose Radiotherapy for Breast Cancer Treatment

June 2, 2021 — A breast cancer therapy that requires just one shot of radiotherapy is as effective as traditional ...

June 02, 2021

A new study finds that brachytherapy, a common procedure that delivers radiation directly to cancer cells, may continue safely, potentially without delay or antibiotics, in cervical cancer patients following uterine perforation.

News | Brachytherapy Systems, Women's Healthcare

Brachytherapy May Continue Following Uterine Perforation in Cervical Cancer Patients

May 19, 2021 — A new study finds that brachytherapy, a common procedure that delivers radiation directly to cancer cells ...

May 19, 2021

iCAD showcasing expanded Xoft Platform including Single-Fraction IORT Solution for brain and early-stage breast cancer tumors

News | Brachytherapy Systems

New Research Presented at ASTRO20 Supports Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers

October 26, 2020 — iCAD, Inc. announced the Company will showcase the expanded platform for the Xoft Axxent Electronic ...

October 26, 2020

Sandra Sha, M.D., a distinguished physician as recognized by the Florida Medical Association, specializing in breast cancer treatment

News | Brachytherapy Systems, Women's Healthcare

Florida Cancer Center Upgrades to AccuBoost Digital

September 8, 2020 — Advanced Radiation Therapy has completed the installation of the AccuBoost Digital platform at the ...

September 08, 2020

News | Brachytherapy Systems, Women's Healthcare

Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform

At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation Therapy, makers of AccuBoost, announced the latest upgrades to the AccuBoost Digital platform. AccuBoost Digital leverages the Planmed Clarity digital mammography system to provide doctors with real-time image-guidance and targeting confidence in the delivery of accelerated partial breast irradiation (APBI) in patients opting for breast conserving therapy (BCT). These upgrades improve the treatment workflow, patient experience and user interface. By design, this non-invasive breast brachytherapy (NIBB) technique is 100 percent adaptive as each treatment fraction is assessed independently and is ideal for the challenges that APBI treatments can present.

October 23, 2019